Drug Patent Expirations for the Week of September 17, 2023

ACTOPLUS MET XR (metformin hydrochloride; pioglitazone hydrochloride) Takeda pharms usa Patent: 8,470,368 Expiration: Sep 19, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical…
The post Drug Patent Expiration…


New patent for Impact drug INREBIC

Annual Drug Patent Expirations for INREBIC Inrebic is a drug marketed by Impact and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent for Impact drug INREBIC appeared first on DrugPatentWa…


Biotechblog